Efficacy and safety of a quail egg homogenate-based dietary supplement as adjunctive therapy in patients with seasonal allergic rhinitis

niversity of Catania0 个研究点目标入组 40 人开始时间: 2020年12月28日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Patients were eligible to participate if the following inclusion criteria were met:
•- age =18 years old;
•- recent diagnosis/clinically relevant history of mild to severe SAR to the most common inhalant allergens prevalent in the geographic area in which the study was carried out;
•- who did not receive any treatment for SAR.

•Patients were excluded from the study if they had any medical condition, such as pregnancy, a respiratory tract infection that could influence the study; uncontrolled asthma; taking an antihistamine, leukotriene receptor antagonist, and decongestant within the week before the study participation; consumption of corticosteroids within the month before the study participation; or known sensitivities to any of the ingredients of the study product.

发起方

niversity of Catania